Advancements in tissue engineering for articular cartilage regeneration

M Chen, Z Jiang, X Zou, X You, Z Cai, J Huang - Heliyon, 2024 - cell.com
Articular cartilage injury is a prevalent clinical condition resulting from trauma, tumors,
infection, osteoarthritis, and other factors. The intrinsic lack of blood vessels, nerves, and …

From cells to organs: progress and potential in cartilaginous organoids research

X Wang, N Liu, H Zhang, Z Yin, ZG Zha - Journal of Translational Medicine, 2023 - Springer
While cartilage tissue engineering has significantly improved the speed and quality of
cartilage regeneration, the underlying metabolic mechanisms are complex, making research …

Cell therapy approaches for articular cartilage regeneration

MJ Makarczyk - Organogenesis, 2023 - Taylor & Francis
Articular cartilage is a common cartilage type found in a multitude of joints throughout the
human body. However, cartilage is limited in its regenerative capacity. A range of methods …

[HTML][HTML] Clinical potential of cellular material sources in the generation of iPSC-based products for the regeneration of articular cartilage

A Eremeev, A Pikina, Y Ruchko… - International Journal of …, 2023 - mdpi.com
Inflammatory joint diseases, among which osteoarthritis and rheumatoid arthritis are the
most common, are characterized by progressive degeneration of the cartilage tissue …

[HTML][HTML] Future perspectives: advances in bone/cartilage organoid technology and clinical potential

J Huang, A Li, R Liang, X Wu, S Jia… - Biomaterials …, 2024 - pmc.ncbi.nlm.nih.gov
Bone and cartilage tissues are essential for movement and structure, yet diseases like
osteoarthritis affect millions. Traditional therapies have limitations, necessitating innovative …

Differentiation of Human Induced Pluripotent Stem Cells (iPSCs)–derived Mesenchymal Progenitors into Chondrocytes

NM Khan, ME Diaz-Hernandez, H Drissi - Bio-protocol, 2023 - bio-protocol.org
Background Human induced pluripotent stem cells (iPSCs) hold great potential for
regenerative medicine, as they can be tailored to patient-specific cells for replacing …